- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02364375
Usability Evaluation of Menai CPAP Masks
Menai Mask Systems - Clinical Study 1
Study Overview
Status
Conditions
Detailed Description
The study will evaluate the subjective seal, comfort, stability, usability, and humidification performance of the prototype mask systems in CPAP established patients. The performance of the prototype Menai mask systems (full face, nasal, and pillows variants) will be subjectively assessed through user questionnaires based on an 11-point Likert scale, and will be compared against Comparison masks.
The prototype masks share the same parts (cushion, frame, headgear), with the difference being that the Menai masks feature a novel vent and humidification system.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New South Wales
-
Sydney, New South Wales, Australia, 2153
- ResMed Sleep Research Centre
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Participants willing to provide written informed consent
- Participants who can read and comprehend written and spoken English
- Participants who are over 18 years of age
- Participants who have been diagnosed with OSA
- Participants who have been established on CPAP for ≥ 6 months
- Participants who are currently using the same mask type/variant as the interventional mask system to be evaluated
Exclusion Criteria:
- Participants who are not able to provide written informed consent
- Participants who are unable to comprehend written and spoken English
- Participants who are pregnant
- Participants who are unsuitable to participate in the study in the opinion of the researcher
- Participants with a pre-existing lung disease or a condition that would predispose them to pneumothorax (e.g. COPD, lung cancer; fibrosis of the lungs; recent (< 2years) case of pneumonia or lung infection, lung injury)
- Participants who cannot participate for the duration of the trial
- Participants who are established on bi-level support therapy
- Participants who are not currently using the same mask type/variant as the interventional mask system to be evaluated
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Full Face
Participants will trial the same mask type/variant (full face, nasal, pillows) as the variant they are using as part of their current treatment.
Participants in this arm will trial the Menai mask (full face) and Comparison Menai Standard mask (full face) for 7 nights each.
|
Prototype mask system (full face variant) with novel vent and humidification system
Prototype mask system (full face variant) with conventional vent and humidification system
|
Experimental: Nasal
Participants will trial the same mask type/variant (full face, nasal, pillows) as the variant they are using as part of their current treatment.
Participants in this arm will trial the Menai mask (nasal) and Comparison Menai Standard mask (nasal) for 7 nights each.
|
Prototype mask system (nasal variant) with novel vent and humidification system
Prototype mask system (nasal variant) with conventional vent and humidification system
|
Experimental: Pillows
Participants will trial the same mask type/variant (full face, nasal, pillows) as the variant they are using as part of their current treatment.
Participants in this arm will trial the Menai mask (pillows) and Comparison Menai Standard mask (pillows) for 7 nights each.
|
Prototype mask system (pillows variant) with conventional vent and humidification system
Prototype mask system (pillows variant) with conventional vent and humidification system
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Usability Performance Evaluation
Time Frame: 2 weeks
|
Evaluation of the usability performance (seal, comfort, etc) of the Menai masks, compared to the Comparison Menai Standard masks.
|
2 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Humidification Performance Evaluation
Time Frame: 2 weeks
|
Evaluation of the humidification performance of the Menai masks (passive humidification), compared to the Comparison Menai Standard masks (active humidification).
|
2 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Klaus Schindhelm, BE PhD, Graduate School of Biomedical Engineering, University of New South Wales, Sydney Australia and Applied Research, ResMed Ltd Sydney Australia
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MA220115
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obstructive Sleep Apnea
-
LivaNovaActive, not recruitingApnea | Obstructive Sleep Apnea | OSA | Apnea, Obstructive | Apnea+Hypopnea | Apnea, Obstructive Sleep | Hypopnea, SleepUnited States
-
Mauro ManconiCompletedObstructive Sleep Apnea Syndrome | Sleep Apnea, Obstructive | Obstructive Sleep Apnea | OSA | Apnea, Obstructive | OSAHSwitzerland
-
University of California, Los AngelesRecruiting
-
Brigham and Women's HospitalCompletedObstructive Sleep Apnea (OSA)United States
-
ApnimedCompletedOSA - Obstructive Sleep ApneaUnited States
-
State Budgetary Healthcare Institution, National...RecruitingObstructive Sleep Apnea | Obstructive Sleep Apnea-hypopnea | Obstructive Sleep Apnea-hypopnea SyndromeRussian Federation
-
ResMedCompletedObstructive Sleep Apnea (OSA)United States, Australia
-
The Hospital for Sick ChildrenCompleted
-
Cryosa, Inc.Active, not recruitingObstructive Sleep Apnea of AdultPanama, Paraguay
Clinical Trials on Menai mask (full face)
-
Fisher and Paykel HealthcareCentre hospitalier de l'Université de Montréal (CHUM); Institut universitaire...Not yet recruitingAcute Hypoxemic Respiratory Failure | Acute Hypercapnic Respiratory Failure
-
Weill Medical College of Cornell UniversityTerminatedObstructive Sleep Apnea (OSA)United States
-
Fisher and Paykel HealthcareCompletedObstructive Sleep ApneaUnited States
-
Fisher and Paykel HealthcareCompletedObstructive Sleep Apnea | Positive Airway Pressure TherapyNew Zealand
-
Fisher and Paykel HealthcareCompletedObstructive Sleep ApneaUnited States
-
Fisher and Paykel HealthcareCompletedObstructive Sleep Apnea | Sleep Disordered BreathingNew Zealand
-
Tufts Medical CenterRhode Island HospitalCompletedAcute Respiratory InsufficiencyUnited States
-
Fisher and Paykel HealthcareTerminatedObesity Hypoventilation SyndromeNew Zealand
-
Fisher and Paykel HealthcareCompletedObstructive Sleep ApneaUnited States
-
Duke UniversityDivers Alert NetworkCompletedFace Mask Squeeze | Snorkeling | Underwater Physiology | Swimming PhysiologyUnited States